Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acadia Pharmaceutica (ACAD)

Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,832,431
  • Shares Outstanding, K 164,772
  • Annual Sales, $ 726,440 K
  • Annual Income, $ -61,290 K
  • 60-Month Beta 0.37
  • Price/Sales 3.87
  • Price/Cash Flow N/A
  • Price/Book 6.42
Trade ACAD with:

Options Overview Details

View History
  • Implied Volatility 51.00% ( +0.16%)
  • Historical Volatility 58.41%
  • IV Percentile 61%
  • IV Rank 38.79%
  • IV High 95.33% on 02/15/24
  • IV Low 22.91% on 11/20/23
  • Put/Call Vol Ratio 5.22
  • Today's Volume 1,299
  • Volume Avg (30-Day) 1,721
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 48,874
  • Open Int (30-Day) 51,022

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.18
  • Number of Estimates 9
  • High Estimate 1.25
  • Low Estimate -0.08
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.60 +2.83%
on 04/16/24
19.00 -10.13%
on 03/21/24
-1.65 (-8.81%)
since 03/18/24
3-Month
16.60 +2.83%
on 04/16/24
29.29 -41.72%
on 01/24/24
-10.52 (-38.13%)
since 01/18/24
52-Week
16.60 +2.83%
on 04/16/24
33.99 -49.78%
on 07/18/23
-2.65 (-13.44%)
since 04/18/23

Most Recent Stories

More News
Stock Futures Ignore Higher-Than-Expected US Inflation Report

March S&P 500 E-Mini futures (ESH24) are trending up +0.30% this morning as market participants awaited the all-important U.S. consumer inflation report that could shed light on the Federal Reserve’s...

ESH24 : 5,101.67s (-1.01%)
BA : 170.23 (+0.01%)
MRVL : 65.24 (-1.87%)
AMD : 155.08 (+0.69%)
BALY : 14.00 (+3.93%)
WCH.D.DX : 106.150 (-0.05%)
ORCL : 116.00 (-2.25%)
ACAD : 17.07 (-0.70%)
MTN : 213.62 (-2.68%)
HRTG : 9.49 (+2.37%)
CVNA : 71.15 (+2.88%)
Acadia: Q4 Earnings Snapshot

Acadia: Q4 Earnings Snapshot

ACAD : 17.07 (-0.70%)
Acadia: Q3 Earnings Snapshot

Acadia: Q3 Earnings Snapshot

ACAD : 17.07 (-0.70%)
Why Acadia Pharmaceuticals Stock Is Rising Today

An analyst upgrade is sparking a rally in the drugmaker's shares today.

JPM : 181.25 (+0.65%)
ACAD : 17.07 (-0.70%)
2 Growth Stocks I'd Buy on the Dip

These two growth stocks could be worthwhile buy-and-holds.

BUD : 57.91 (+0.96%)
ACAD : 17.07 (-0.70%)
TLRY : 1.7200 (unch)
2 Supercharged Growth Stocks Billionaires Can't Stop Buying

A top hedge fund has been steadily buying these two growth stocks in 2023.

PFE : 25.39 (-0.12%)
ACAD : 17.07 (-0.70%)
ROIV : 10.36 (-0.77%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 37.81 (-0.55%)
KNSA : 16.88 (-0.41%)
ACAD : 17.07 (-0.70%)
HRMY : 29.03 (-0.55%)
AMPH : 38.65 (-3.50%)
INCY : 52.82 (+0.19%)
AGEN : 4.97 (-7.96%)
NVS : 92.57 (-0.55%)
PFE : 25.39 (-0.12%)
SGEN : 228.74 (-0.07%)
MRK : 125.23 (-0.11%)
RXDX : 199.92 (+0.09%)
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?

This biotech stock has been on fire in 2023.

ACAD : 17.07 (-0.70%)
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street

This small-cap biotech might be a hidden gem.

ACAD : 17.07 (-0.70%)
STOK : 11.65 (-0.60%)
Acadia: Q2 Earnings Snapshot

Acadia: Q2 Earnings Snapshot

ACAD : 17.07 (-0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative medicines to address the unmet medical needs in central nervous system (CNS) disorders. The company's sole marketed drug Nuplazid (pimavanserin) is the first and the only FDA-approved treatment for hallucinations...

See More

Key Turning Points

3rd Resistance Point 17.62
2nd Resistance Point 17.48
1st Resistance Point 17.28
Last Price 17.07
1st Support Level 16.94
2nd Support Level 16.80
3rd Support Level 16.60

See More

52-Week High 33.99
Fibonacci 61.8% 27.35
Fibonacci 50% 25.30
Fibonacci 38.2% 23.24
Last Price 17.07
52-Week Low 16.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar